Please login to the form below
Evoq Therapeutics
This page shows the latest Evoq Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Amgen plans acquisition of Rodeo Therapeutics
Amgen has agreed to acquire US-based biopharma company Rodeo Therapeutics to strengthen its anti-inflammatory portfolio. ... Earlier this year, Amgen also entered into a licence and collaboration agreement with Evoq Therapeutics to develop novel drugs
Latest news
-
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
Companies will collaborate on novel drugs for autoimmune disorders. Amgen has entered into a license and collaboration agreement with Evoq Therapeutics worth over $240m, with the aim of developing novel drugs ... In a preclinical ‘gold-standard’
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
CEO Pricing & Market Access, UK
-
Six figure salary
-
Omnichannel Strategy Consultant
-
Competitive Salary
-
Senior Account Manager
-
Competitive salary offered
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- US demand for COVID-19 antibody treatments rising fast
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Biogen's ALS drug tofersen misses phase 3 endpoint
- What does HCP engagement look like in a post-Covid world?
- Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Valneva COVID-19 vaccine more effective than AZ
- Real-world data highlights flu vaccine efficacy
- Biosimilars boosted by FDA's landmark ruling for Boehringer’s Cyltezo
- Vertex moves ahead with its bid to develop a curative treatment for type 1 diabetes
No results were found
PMHub
McCann Health Medical Communications
We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....
Latest intelligence
- What does HCP engagement look like in a post-Covid world?
- HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...
- Breaking the silence: It’s time to talk about the menopause
- Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
- Committing time to making meaningful connections - top 5 tips
- Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
